An interventional study of TTM-Based Educational Program in Human Papillomavirus (HPV), Papillomavirus Vaccines and Health Knowledge, Attitudes, Practice, sponsored by Cukurova University. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-27.
Sponsored by Cukurova University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 73 studies in Health Behavior with a site in Turkey — 15 open to participants now, 17 under way, none of them phase 3. Health Behavior · Turkey.
Among the 73 studies in Health Behavior with a site in Turkey, this one is the 26th largest by planned enrollment of the 62 interventional ones that give a count, is one of 6 that started in 2026, is one of 62 with no phase, reaches primary completion later than 10 of the 16 other live ones, and was the 59th registered.
970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.
Browse Health Behavior studies →15 of the 73 studies in Health Behavior with a site in Turkey are open now. Recruiting first, the newest first:
Selcuk University · Sites in Turkey
Ages 12–13 · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 40+ · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 18–25 · Healthy volunteers
Akdeniz University · Sites in Turkey
Ages 30–70 · Women only · Healthy volunteers
Population Health Research Institute · Sites in Turkey, Argentina, Bangladesh and 22 more countries
Ages 35–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 94 Health Behavior studies recruiting now, 39 (41%) set no upper age limit and 38 (40%) stop at 75 or younger; 25 take children under 18; 59 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
73 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 6 started in 2026.
This study's planned enrollment of 88 is below the median of 150 across 826 interventional studies indexed under Health Behavior.
Median enrollment 79 across the 62 interventional studies, 153 across the 11 observational. Of the 54 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 73 has an industry lead sponsor. The 10 most frequent:
Cukurova University is the lead sponsor of 261 studies on the registry; 48 are open to participants now.
Cukurova University has 1 study filed under Health Behavior — fewer than ten, so there is no comparison to draw.
1 of the studies in Health Behavior with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06497816Hacettepe UniversityHealth Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD | 2027-06-15 |
Add it to your calendar (.ics) → With an account.
Among the 73 studies in Health Behavior with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to examine the impact of a structured educational program based on the Transtheoretical Model (TTM) on HPV knowledge, health beliefs, and vaccination behavioral intentions among first-year nursing students. The study will also evaluate how the intervention affects students' HPV vaccine readiness compared to the TTM.
The primary questions addressed by the study are:
The researcher will compare the TTM-based educational intervention with a control group that did not receive structured education to determine whether a personalized, stage-based approach is more effective in improving HPV-related outcomes among nursing students.
Participants will:
The TTM-based educational intervention provides:
The study population included first-year nursing students enrolled in the Faculty of Health Sciences. A total of 88 participants will be recruited and randomly assigned to either the intervention (n=44) or control (n=44) groups through simple randomization.
The results of this study are expected to contribute to the development of evidence-based education strategies in nursing, support of behavioral change models in health education, and strengthen the role of future nurses in HPV prevention, vaccine advocacy, and public health practice.
970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.
This study's planned enrollment of 88 is below the median of 150 across 826 interventional studies indexed under Health Behavior.
Browse Health Behavior studies →Cukurova University is the lead sponsor of 261 studies on the registry; 48 are open to participants now.
Compared within Health Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TTM-based structured educational program tailored to the participant's stage of readiness for HPV vaccination
Behavioral: TTM-Based Educational Program
No structured education; participants receive no TTM-based training during the study period.
A structured, stage-matched educational intervention based on the Transtheoretical Model, delivered face-to-face in five modules aligned with Precontemplation, Contemplation, Preparation, Action, and Maintenance stage
Vaccination Behavior Intention Scale
Behavioral intention to receive the HPV vaccine will be assessed using the HPV Vaccination Intention Scale, a 6-item instrument developed based on the Theory of Planned Behavior. The scale evaluates participants' intention to receive the HPV vaccine, with higher scores indicating stronger intention to be vaccinated. The secondary outcome is the change in intention score from baseline to post-intervention.
Time frame: Baseline and after completion of the 10-week intervention (5 sessions delivered every 2 weeks)
HPV Knowledge Scale
HPV knowledge will be measured using the HPV Knowledge Scale (HPV-BS), a validated 33-item instrument consisting of four subscales: general HPV knowledge (16 items), HPV screening knowledge (6 items), HPV vaccine knowledge (5 items), and HPV vaccination program knowledge (6 items). Total scores range from 0 to 35, with higher scores indicating greater knowledge about HPV infection, transmission, screening, and vaccination. A Cronbach's alpha coefficient of 0.96 was reported in the Turkish validity and reliability study. The primary outcome is the change in total HPV knowledge score from baseline to postintervention.
Time frame: Baseline and after completion of the 10-week intervention (5 sessions delivered every 2 weeks)
Health Belief Model Scale regarding HPV and vaccination
Health beliefs regarding HPV and HPV vaccination will be measured using the Health Belief Model Scale (HBM-HPV), a validated instrument developed by Kim (2016) and adapted into Turkish by Guvenc et al. (2016). The scale consists of four subscales: perceived benefits (items 1-3), perceived susceptibility (items 4-5), perceived severity (items 6-9), and perceived barriers (items 10-13 and 15). Higher scores indicate stronger beliefs within each construct. Except for perceived barriers, all subscales are positively associated with HPV vaccination intention. Cronbach's alpha values for the subscales range from 0.71 to 0.78. The secondary outcome is the change in subscale scores from baseline to post-intervention.
Time frame: Baseline and after completion of the 10-week intervention (5 sessions delivered every 2 weeks)
Plan to share: No — Individual participant data (IPD) will not be shared because the study involves identifiable student information, and sharing raw data may pose confidentiality and privacy risks. Data will be stored securely and used only for the purposes approved by the ethics committee. Only aggregated and de-identified results will be reported in publications.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Mar 2026, 2 months after the start.
Of 569 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 2 months is below that.
Counting every sponsor, half of 587 studies reached it within 15 months; a quarter within 5 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.